Archives

by in
Entry Author Date Location
ZS Pharma Raises $55M to Develop Drug to Treat Hyperkalemia 03/06/14 Texas
ZS Pharma Secures $55,000,000 Series D Financing Round 03/06/14 Texas
Versartis Lands $55,000,000 Series E Financing 02/18/14 San Francisco
Flexion Prices IPO at $13, Heads to Nasdaq Tomorrow 02/11/14 Boston
First Aid Shot Therapy Obtains Series B Financing Round 02/10/14 San Francisco
Shockwave Medical Garners $12,500,000 Series A Financing 01/29/14 Seattle
Flexion Files for IPO, Seeks $86M to Develop Osteoarthritis Drugs 01/08/14 Boston
Green Biologics Receives $25,000,000 Series B Financing 12/05/13 Detroit
Versartis Garners $20,000,000 Series D Financing Round 10/08/13 San Francisco
San Diego Life Sciences Roundup: Regulus, Ocera, Lithera, and More 07/18/13 San Diego
Crocus Technology Lands $45,000,000 New Financing 07/11/13 San Francisco
East Coast Life Sciences Roundup: Epizyme, Alkermes, Ophthotech, & More 05/31/13 Boston
First Aid Shot Therapy Secures Series A Funding 05/22/13 San Francisco
Three VCs See New Opportunities as Changes Roil Venture Industry 01/24/13 San Diego
2012 VC Funding Strong in Software, Soft Elsewhere: The Top 10 Deals 01/18/13 National
Guavus Obtains $30,000,000 New Financing Round 01/10/13 San Francisco
Labrys Biologics Secures $31,000,000 Series A Funding Round 01/04/13 San Francisco
Flexion Therapeutics Obtains $20,000,000 Series B Funding 12/04/12 Boston
Exclusive: Skyline Ventures Cuts Partners, Postpones Fundraising 10/26/12 National
Mirna Therapeutics Secures $34,500,000 Series C Funding Round 10/24/12 Texas
Who Will Survive the Biotech VC Downturn? The Young and the Proven 10/22/12 National
San Diego’s Cebix Names CEO, Raises $30.9M to Advance Diabetes Drug 10/17/12 San Diego
Which VCs Are Poised to Cash In On the Biotech IPOs of 2012? 10/15/12 National
Alzheimer’s R&D Isn’t Doomed, it’s Learning From Failure 08/20/12 National
Kayak, VMware, 3M, & More Names from the Boston Deal Roundup 07/25/12 Boston
Histogenics Brings In $49M for Tissue Regeneration—and Recapitalization 07/24/12 Boston
Histogenics Obtains $49,000,000 Series A Funding 07/24/12 Boston
Histogenics Receives $49,000,000 Series A Round 07/24/12 Boston
San Diego Life Sciences Roundup: Halozyme, Sophiris, Arena, & More 07/12/12 San Diego
Sophiris Moves to Unlock Blockbuster Potential in New Prostate Drug 07/10/12 San Diego
Page 1 of 4 next page »